Ovidrel (EMD Serono, Inc.)


Welcome to the PulseAid listing for the Ovidrel drug offered from EMD Serono, Inc.. This Gonadotropin [EPC],Gonadotropins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: EMD Serono, Inc.
NON-PROPRIETARY NAME: choriogonadotropin alfa
SUBSTANCE NAME: CHORIOGONADOTROPIN ALFA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Gonadotropin [EPC],Gonadotropins [Chemical/Ingredient]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2003-10-06
END MARKETING DATE: 0000-00-00


Ovidrel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOvidrel from EMD Serono, Inc.
LABELER NAME: EMD Serono, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(ug/.5mL)
START MARKETING DATE: 2003-10-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44087-1150_aa66e33f-3db4-4658-b31f-aef336eca26d
PRODUCT NDC: 44087-1150
APPLICATION NUMBER: NDA021149

Other CHORIOGONADOTROPIN ALFA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
EMD Serono, Inc.Ovidrel